• 1
    Kumari, A., Yadav, S.K. and Yadav, S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloid Surf B-Biointerfaces. 75, 118 (2010).
  • 2
    Piskin, E. Biodegradable polymers as biomaterials. J. Biomater. Sci. Polymer. Edn. 6, 775795 (1994).
  • 3
    Prausnitz, M.R., Mitragotri, S. and Langer, R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3, 115124 (2004).
  • 4
    Winsor, T. and Burch, G.E. Rate of invisible perspiration through living and dead stratum corneum. Arch. Int. Med. 74, 437 (1944).
  • 5
    Monash, H. Location of the superficial barrier to skin penetration. J. Invest. Derm. 29, 367 (1957).
  • 6
    Malkinson, F.D. Studies in the percutaneous absorption of C14 labeled steroid by use of the gas flow cell. J. Invest. Derm. 31, 19 (1958).
  • 7
    Kligman, A.M. The biology of the stratum corneum. In: The Epidermis. (Montagna, W.Lobitz, W.B., eds.), pp. 387433. Academic Press, New York (1964).
  • 8
    Blank, I.H. Transport across the stratum corneum. Toxicol. Appl. Pharmacol. 14, (Supplement 3)2329 (1969).
  • 9
    Blank, I.H. and Scheuplein, R.J. Permeability of the skin. Physiol. Rev. 51, 702747 (1971).
  • 10
    Elias, P.M. The epidermal permeability barrier: from the early days at harvard to emerging concepts. J. Investig. Dermatol. 122, xxxvixxxix (2004).
  • 11
    Association of the British Pharmaceutical Industry (ABPI). Skin Structure and Function. Available at:, accessed 27 March 2012.
  • 12
    Elias, P.M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80(1s), 44s49s (1983).
  • 13
    Harding, C.R. The stratum corneum: structure and function in health and disease. Dermatol. Ther. 17, 615 (2004).
  • 14
    Förster, M., Bolzinger, M.-A., Fessi, H. and Briançon, S. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. Eur. J. Derm. 19, 309323 (2009).
  • 15
    Moghimi, H.R., Williams, A.C. and Barry, B.W. Stratum corneum and barrier performance; a model lamellar structural approach. In: Percutaneous Absorption. (Bronaugh, R.L. and Maibach, H.I., eds.), pp. 515553. Marcel Dekker, New York (1999).
  • 16
    Barbero, A.M. and Frasch, H.F. Transcellular route of diffusion through stratum corneum: results from finite element models. J. Pharm. Sci. 95, 21862194 (2006).
  • 17
    Chen, L., Lian, G. and Han, L. Use of “Bricks and Mortar” model to predict transdermal permeation: model development and initial validation. Ind. Eng. Chem. Res. 47, 64656472 (2008).
  • 18
    Chen, L., Lian, G. and Han, L. Modeling transdermal permeation. Part I. Predicting skin permeability of both hydrophobic and hydrophilic solutes. AIChE J. 56, 11361146 (2010).
  • 19
    Mitragotri, S., Anissimov, Y.G., Bunge, A.L. et al. Mathematical models of skin permeability: an overview. Int. J. Pharm. 418, 115129 (2011).
  • 20
    Cross, S.E. and Roberts, M.S. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr. Drug Deliv. 1, 8192 (2004).
  • 21
    Guy, R.H. Current status and future prospects of transdermal drug delivery. Pharm. Res. 13, 17651769 (1996).
  • 22
    Park, J.-H., Allen, M. and Prausnitz, M. Polymer microneedles for controlled-release drug delivery. Pharm. Res. 23, 10081019 (2006).
  • 23
    Pawar, K.R. and Babu, R.J. Polymeric and lipid-based materials for topical nanoparticle delivery systems. Crit. Rev. Ther. Drug Carr. Syst. 27, 419459 (2010).
  • 24
    He, W., Guo, X., Xiao, L. and Feng, M. Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers. Int. J. Pharm. 382, 234243 (2009).
  • 25
    Cattaneo, M.V. Topical delivery systems based on polysaccharide microspheres. In: Delivery System Handbook for Personal Care and Cosmetic Products. (Rosen, M.R., ed.), pp. 273282. William Andrew, Inc., Norwich, NY (2005).
  • 26
    Cattaneo, M., Chitosan Microparticles for the Topical Delivery of Water Insoluble Active Agents. US patent 2004247632. IVREA, Inc., Qunicy, MA. (2004).
  • 27
    Wang, X., Xu, W., Mohapatra, S., Kong, X., Li, X., Lockey, R. and Mohapatra, S. Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genet. Vacc. Ther. 6, 7 (2008).
  • 28
    Mishra, N., Goyal, A.K., Khatri, K. et al. Biodegradable polymer based particulate carrier(s) for the delivery of proteins and peptides. AntiInflam. Antiallergy Agents Med Chem 7, 240251 (2008).
  • 29
    Ghosn, B., van de Ven, A.L., Tam, J., Gillenwater, A., Sokolov, K.V., Richards-Kortum, R. et al. Efficient mucosal delivery of optical contrast agents using imidazole-modified chitosan. J. Biomed. Opt. 15, 015003 (2010).
  • 30
    Pedro, A.S., Cabral-Albuquerque, E., Ferreira, D. and Sarmento, B. Chitosan: an option for development of essential oil delivery systems for oral cavity care? Carbohydr. Polym. 76, 501508 (2009).
  • 31
    Basavaraj, K.H., Johnsy, G., Navya, M.A., Rashmi, R. and Siddaramaiah. Biopolymers as transdermal drug delivery systems in dermatology therapy. Crit. Rev. Ther. Drug. Carr. Syst.. 27:155185 (2010).
  • 32
    Pavicic, T., Gauglitz, G.G., Lersch, P., Schwach-Abdellaoui, K., Malle, B., Korting, H.C. and Farwick, M. Efficacy of cream-based novel formulations of Hyaluronic Acid of different molecular weights in anti-wrinkle treatment. J. Drugs Dermatol. 10, 9901000 (2011).
  • 33
    Price, R.D., Berry, M.G. and Navsaria, H.A. Hyaluronic acid: the scientific and clinical evidence. J. Plast. Reconstr. Aesthet. Surg. 60, 11101119 (2007).
  • 34
    Teh, B.M., Shen, Y., Friedland, P.L., Atlas, M.D. and Marano, R.J. A review on the use of hyaluronic acid in tympanic membrane wound healing. Expert. Opin. Biol. Ther. 12, 2336 (2012).
  • 35
    Abbruzzese, L., Rizzo, L., Fanelli, G., Tedeschi, A., Scatena, A., Goretti, C., Macchiarini, S. and Piaggesi, A. Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial. Int. J. Low Extrem. Wounds. 8, 134140 (2009).
  • 36
    Kong, M. and Park, H.J. Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohydr. Polym. 83, 13031310 (2011).
  • 37
    Kong, M., Chen, X.G., Kweon, D.K. and Park, H.J. Investigations on skin permeation of hyaluronic acid based nanoemulsion as transdermal carrier. Carbohydr. Polym. 86, 837843 (2011).
  • 38
    Brown, M.B. and Jones, S.A. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J. Eur. Acad. Derm. Venereol. 19, 308318 (2005).
  • 39
    Matsuda, H. and Arima, H. Cyclodextrins in transdermal and rectal delivery. Adv. Drug Deliv. Rev. 36, 8199 (1999).
  • 40
    Gonnet, M., Lethuaut, L. and Boury, F. New trends in encapsulation of liposoluble vitamins. J. Control Release. 146, 276290 (2010).
  • 41
    Scalia, S., Villani, S., Scatturin, A., Vandelli, M.A. and Forni, F. Complexation of the sunscreen agent, butyl-methoxydibenzoylmethane, with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 175, 205213 (1998).
  • 42
    Tarimci, N. Cyclodextrins in the cosmetic field. In: Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications. (Bilensoy, E., ed.), pp. 131144. John Wiley & Sons, Inc., Hoboken, NJ (2011).
  • 43
    Kear, C.L., Yang, J., Godwin, D.A. and Felton, L.A. Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery. Drug Dev. Ind. Pharm. 34, 692697 (2008).
  • 44
    Lee, K.Y. and Mooney, D.J. Alginate: properties and biomedical applications. Prog. Polym. Sci. 37, 106126 (2012).
  • 45
    Solomon, M.C. and Oraceska, B., Cross-linked Alginate Transdermal Medicine Delivery Devices. US patent 5484604. Chatfield Pharmaceuticals Ltd., Kramer Mews, England, (1996).
  • 46
    Elmotasem, H. Chitosan-alginate blend films for the transdermal delivery of meloxicam. J. Pharm. Sci. 3, 1229 (2008).
  • 47
    Handjani, R.M., Kauffmann, M. and Huguenin, F., Process for the Preparation of Alginate Capsules, Apparatus for producing said Capsules and Cosmetic Compositions Containing said Capsules. US patent 5204111. L'Oreal, Paris, France, (1993).
  • 48
    Viyoch, J., Patcharaworakulchai, P., Songmek, R., Pimsan, V. and Wittaya-Areekul, S. Formulation and development of a patch containing tamarind fruit extract by using the blended chitosan-starch as a rate-controlling matrix. Int. J. Cosmet. Sci. 25, 113125 (2003).
  • 49
    Freers, S.O. Starch-based delivery systems. In:Delivery System Handbook for Personal Care and Cosmetic Products: Technology, Applications and Formulations. (Rosen, M.R., ed.), pp. 741760. William Andrew Inc., Norwich, NY (2005).
  • 50
    Wille, J.J., Methods for Preparation of a Thixotropic Microemulsion for Skin Care Formulations. US patent 2010098734. Individual, Chesterfield, NJ (2010).
  • 51
    Wille, J.J. Thixogel: a starch matrix encapsulation technology for topical drug and cosmetic delivery. In: Skin Delivery Systems: Transdermals, Dermatologicals and Cosmetic Actives. (Wille, J.J., ed.), pp. 223245. Blackwell Publishing, Oxford, UK (2006).
  • 52
    Mourtzinos, I., Papadakis, S.E., Igoumenidis, P. and Karathanos, V.T. Encapsulation of Melissa Officinalis leaf's active compounds in β-cyclodextrin and modified starch. Procedia Food Science. 1, 16791685 (2011).
  • 53
    Compton, D.L., Kenar, J.A., Laszlo, J.A. and Felker, F.C. Starch-encapsulated, soy-based, ultraviolet-absorbing composites with feruloylated monoacyl- and diacylglycerol lipids. Ind. Crops Prod. 25, 1723 (2007).
  • 54
    Sinha, V.R., Bansal, K., Kaushik, R., Kumria, R. and Trehan, A. Poly-&epsi-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 278, 123 (2004).
  • 55
    Cha, Y. and Pitt, C.G. The biodegradability of polyester blends. Biomaterials 11, 108112 (1990).
  • 56
    Vaida, C., Mela, P., Kunna, K., Sternberg, K., Keul, H. and Möller, M. Microparticles for drug delivery based on functional polycaprolactones with enhanced degradability: loading of hydrophilic and hydrophobic active compounds. Macromol. Biosci. 10, 925933 (2010).
  • 57
    Sinha, V.R. and Trehan, A. Biodegradable microspheres for protein delivery. J. Control Release. 90, 261280 (2003).
  • 58
    Ye, M., Kim, S. and Park, K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release. 146, 241260 (2010).
  • 59
    Gu, H. and Roy, K. Topical permeation enhancers efficiently deliver polymer micro and nanoparticles to epidermal Langerhans' cells. J. Drug Deliv. Sci. Tech. 14, 265273 (2004).
  • 60
    Kim, H., Kim, M., Quan, Y. et al. Novel anti-wrinkle effect of cosmeceutical product with new retinyl retinoate microsphere using biodegradable polymer. Skin Res. Tech. 18, 7076 (2012).
  • 61
    Haddadi, A., Aboofazeli, R., Erfan, M. and Farboud, E.S. Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams. J. Microencapsul. 25, 379386 (2008).
  • 62
    Stevanović, M., Savić, J., Jordović, B. and Uskoković, D. Fabrication, in vitro degradation and the release behaviours of poly(dl-lactide-co-glycolide) nanospheres containing ascorbic acid. Colloids Surf., B 59, 215223 (2007).
  • 63
    Alvarez-Román, R., Naik, A., Kalia, Y., Guy, R.H. and Fessi, H. Skin penetration and distribution of polymeric nanoparticles. J. Control Release. 99, 5362 (2004).
  • 64
    Dermabond topical skin adhesive. Int. J. Trauma Nurs. 5:2931 (1999).
  • 65
    Handjani, R.-M. and Ribier, A., Composition for the Cosmetic and/or Pharmaceutical Treatment of the Upper Layers of the Epidermis by Topical Application to the Skin, and Corresponding Preparation Process. US patent 20010010824. L'Oreal, Paris, France (2001).
  • 66
    Eichman, J.D., Bielinska, A.U., Kukowska-Latallo, J.F., Donovan, B.W. and Baker, J.R. Bioapplications of PAMAM Dendrimers. In: Dendrimers and Other Dendritic Polymers. (Frechet, J.M.J. and Tomalia, D.A., eds.), pp. 441461. John Wiley & Sons, Ltd, New York (2002).
  • 67
    Parveen, S., Misra, R. and Sahoo, S.K. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed. Nanotechnol. Biol. Med. 8, 147166 (2012).
  • 68
    Mourey, T.H., Turner, S.R., Rubinstein, M., Frechet, J.M.J., Hawker, C.J. and Wooley, K.L. Unique behaviour of dendritic macromolecules - intrinsic viscosity of polyether dendrimers. Macromolecules 25, 24012406 (1992).
  • 69
    Tournilhac, F. and Simon, P., Cosmetic or Dermatological Topical Compositions Comprising Dendritic Polyesters. US patent US6287552. L'Oreal, Paris, France (2001).
  • 70
    Forestier, S., Rollat-Corvol, I. and Rollat, C.I., Deodorant Composition and Use Thereof patent US6001342. L'Oreal, Paris, France (1999).
  • 71
    Allard, D. and Forestier, S., Composition Comprises Active Self Bronzing Agent and Dendrimer Type Polymer – used for Artificial Tanning of Skin, gives more Rapid Development of Skin Colour and Brown Shade which closely resembles Natural Sun Tanning Patent US6399048-B1. L'Oreal, Paris, France (2002).
  • 72
    Snyder, F., Wolf, B.A. and Snyden, F., Cosmetic Compositions having Keratolytic and Anti-Acne Activity. US patent 5449519. Revlon Consumer products Corp. New York, NY, (1995).
  • 73
    Filipowicz, A. and Wołowiec, S. Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers. Int. J. Pharm. 408, 152156 (2011).
  • 74
    Cheng, Y., Qu, H., Ma, M., Xu, Z., Xu, P., Fang, Y. and Xu, T. Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study. Eur. J. Med. Chem. 42, 10321038 (2007).
  • 75
    Starpharma Dendrimer Platform Technology. Available at:, accessed 9 August 2012.
  • 76
    Sun, M.J., Fan, A.P., Wang, Z. and Zhao, Y.J. Dendrimer-mediated drug delivery to the skin. Soft Matter 8, 43014305 (2012).
  • 77
    Bilati, U., Allemann, E. and Doelker, E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur. J. Pharm. Biopharm. 59, 375388 (2005).
  • 78
    Perez, C., Castellanos, I.J., Costantino, H.R., Al-Azzam, W. and Griebenow, K. Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. J. Pharm. Pharmacol. 54, 301313 (2002).